SCHEMBL15829240

SCHEMBL15829240

COc1ccc(C(C)(C)C)cc1C(=O)NCCN

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ LMNA P02545 2/20 0.47
▸ PPARA Q07869 4/20 0.46
▸ ESRRG P62508 1/20 0.45
▸ DNMT3A Q9Y6K1 1/20 0.45
▸ PPARD Q03181 2/20 0.45
▸ NLRP3 Q96P20 1/20 0.44
▸ NR1H4 Q96RI1 1/20 0.44
▸ ADRA2A P08913 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ DRD3 P35462 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ STAT6 P42226 1/20 0.44
▸ KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15829370 0.84 KMT2A (0.56) MEN1KMT2ALMNAPPARAADRA2A
SCHEMBL15829270 0.83 MEN1 (0.50) MEN1KMT2ALMNAPPARADNMT3A
SCHEMBL13962498 0.83 SIGMAR1 (0.55) LMNADNMT3ANLRP3ADRA2ACYP2D6
SCHEMBL15828696 0.83 ESRRG (0.50) MEN1KMT2ALMNAESRRGNR1H4
SCHEMBL6363486 0.81 ALDH1A1 (0.58) MEN1KMT2APPARAESRRGDNMT3A
Hydrochloric Acid SCHEMBL9585195 0.80 LMNA (0.70) MEN1KMT2ALMNADNMT3ANLRP3
SCHEMBL6360883 0.79 NLRP3 (0.59) PPARAESRRGDNMT3APPARDNLRP3
SCHEMBL22944545 0.78 LMNA (0.47) LMNAPPARADNMT3APPARDNLRP3
SCHEMBL12515357 0.78 MEN1 (0.50) MEN1KMT2ALMNAADRA2ACYP2D6
SCHEMBL3365176 0.77 CTSD (0.68) MEN1KMT2ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210032207-A1 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2021-02-04 — — US disclosed
US-20200055823-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2020-02-20 — — US disclosed
US-20190077762-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2019-03-14 — — US disclosed
US-20170362180-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2017-12-21 — — US disclosed
US-20160340314-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2016-11-24 — — US disclosed
US-9440951-B2 Quinolone compound OTSUKA PHARMACEUTICAL CO., LTD (JP) 2016-09-13 — — US disclosed
US-20150239865-A1 QUINOLONE COMPOUND OTSUKA PHARMA CO LTD (JP) 2015-08-27 — — US disclosed
US-9067887-B2 Quinolone compound OTSUKA PHARMACEUTICAL CO., LTD (JP) 2015-06-30 — — US disclosed
US-20150005287-A2 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-01 — — US disclosed
US-20140179675-A1 QUINOLONE COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239865-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 MEN1 4633/4885KMT2A 3699/4885LMNA 4130/4885
US-20170362180-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 MEN1 4633/4885KMT2A 3699/4885LMNA 4130/4885
US-20200055823-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 MEN1 4633/4885KMT2A 3699/4885LMNA 4130/4885
US-20160340314-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 MEN1 4633/4885KMT2A 3699/4885LMNA 4130/4885
US-20150005287-A2 QUINOLONE COMPOUND HAX1, NQO2, VIP MEN1 4655/4885KMT2A 3808/4885LMNA 4065/4885
US-20190077762-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 MEN1 4651/4885KMT2A 3807/4885LMNA 4152/4885
US-20140179675-A1 QUINOLONE COMPOUND HAX1, NQO2, NHERF1 MEN1 4633/4885KMT2A 3699/4885LMNA 4130/4885
US-20210032207-A1 QUINOLONE COMPOUND HAX1, NQO2, CXCR1 MEN1 4648/4885KMT2A 3191/4885LMNA 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback